Galectin-3: can it be a diagnostic tool for pneumonia in covid-19 patients?

Conclusion: Galectin-3 was found as a diagnostic tool for COVID-19 associated typical pneumonia and as an indicator of both pneumonia and its severity.Key words: Galectin-3, covid-19, pneumonia

📌 3 Key Takeaways

🎯

Objective & Hypothesis:Background/aim: Biochemical markers are needed to show lung involvement in COVID-19 disease.

📊

Key Findings & Data:Galectin-3 is known to play a key role in the inflammation and fibrosis process.

💡

Conclusion & Impact:Conclusion: Galectin-3 was found as a diagnostic tool for COVID-19 associated typical pneumonia and as an indicator of both pneumonia and its severity.Key words: Galectin-3, covid-19, pneumonia

🔬Design:Modeling & Simulation

📍Scope:Comprehensive Sample

⚙️Variables:Domain Parameters

Abstract

Background/aim: Biochemical markers are needed to show lung involvement in COVID-19 disease. Galectin-3 is known to play a key role in the inflammation and fibrosis process. We aimed to evaluate the predictive role of galectin-3 levels for pneumonia in patients with COVID-19. Materials and methods: Total of 176 patients with COVID-19, confirmed with reverse transcriptase polymerase chain reaction, admitted to the Erzurum Regional Training and Research Hospital was analyzed. The study was designed as a cross sectional. The baseline data of laboratory examinations, including galectin-3 were collected at the time of diagnosis. CT images evaluated by a single radiologist according to the recommendation of the Radiological Society of North America Expert Consensus Document for pulmonary involvement. The severity of COVID-19 pneumonia was assessed using the total severity score. Results: The mean galectin-3 level in patients with typical pneumonia was found to be significantly higher than those patients with atypical (p < 0.01) and indeterminate appearance (p < 0.01) and patients without pneumonia (p < 0.01). The severity of lung involvement was significantly associated with Galectin-3 levels (p < 0.01 r: 0.76). Stepwise logistic regression model showed that the levels of ferritin (odds ratio [OR] = 0.05, p: 0.08) and galectin-3 (OR = 0.1, p < 0.01) were significantly and independently associated with typical pneumoniain COVID-19 patients. When COVID-19 patients were evaluated in terms of typical pneumonia, we determined a cut-off value of 18.9 ng/mL for galectin-3 via ROC analysis (87% sensitivity; 73% specificity; area under curve (AUC): 0.89; p < 0.001). Conclusion: Galectin-3 was found as a diagnostic tool for COVID-19 associated typical pneumonia and as an indicator of both pneumonia and its severity.Key words: Galectin-3, covid-19, pneumonia

🔖

Cite This Article

YAVUZ, Y. C., KARAŞAHİN, Ö., KAHRAMAN, M., SEVİNÇ, C., CERRAH, S., ŞEBİN, E., GÖĞEBAKAN, H., BAYKAN, A. R., BAYKAN, E. K. (2022). Galectin-3: can it be a diagnostic tool for pneumonia in covid-19 patients?. Turkish Journal of Medical Sciences, Cilt: 51 - Sayı: 5, 2256–2262. https://ajindex.com/articles/609483

📄 Full Text PDF Viewer

Open in New Tab ↗

↗New Tab

📄

PDF görüntüleyici hazırlanıyor...

References (1)

Shi Y, Wang G, Cai XP, Deng JW, Zheng L et al. An overview of COVID-19. Journal of Zhejiang University Science B (Biomedicine & Biotechnology) 2020; 21 (5): 343-360. doi: 10.1631/jzus.B2000083 2. Zu ZY, Jiang MD, Xu PP, Chen W, Ni QQ et al. Coronavirus disease 2019 (COVID-19). A Perspective From China Radiology 2020; 296 (2): E15-E25. doi: 10.1148/radiol.2020200490 3. Chams N, Chams S, Badran R, Shams A, Araji A et al. COVID-19: a multidisciplinary review. Front Public Health 2020; 29 (8): 383. doi: 10.3389/fpubh.2020.00383 4. Rodrigues JCL, Hare SS, Edey A, Devaraj A, Jacob J et al. An update on COVID-19 for the radiologist - A British Society of Thoracic Imaging Statement. Clinical Radiology 2020; 75 (5): 323-325. doi: 10.1016/j.crad.2020.03.003 5. Harapan H, Itoh N, Yufika A, Winardi W, Keam S et al. Coronavirus disease 2019 (COVID-19): a literature review. Journal of Infection and Public Health 2020; 13 (5): 667-673. doi: 10.1016/j.jiph.2020.03.019 6. Caniglia JL, Asuthkar S, Tsung AJ, Guda MR, Velpula KK. Immunopathology of galectin-3: an increasingly promising target in COVID-19. F1000 Research 2020; 1 (9): 1078. doi: 10.12688/f1000research.25979.2 7. MacKinnon AC, Farnworth SL, Hodkinson PS, Henderson NC, Atkinson KM et al. Regulation of alternative macrophage activation by galectin-3. Journal of Immunology 2008; 180 (4): 2650-2658. doi: 10.4049/jimmunol.180.4.2650 8. Xu Z, Li X, Huang Y, Mao P, Wu S et al. The Predictive value of plasma galectin-3 for ards severity and clinical outcome. Shock 2017; 47 (3): 331-336. doi: 10.1097/SHK.0000000000000757.9 9. De Biasi S, Meschiari M, Gibellini L, Bellinazzi C, Borella R et al. Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia. Nature Communications 2020; 11 (1): 3434. doi: 10.1038/s41467-020- 17292-4 10. Kalfaoglu B, Almeida-Santos J, Tye CA, Satou Y, Ono M. T-cell hyperactivation and paralysis in severe COVID-19 infection revealed by single-cell analysis. Frontiers in Immunology 2020; 8 (11): 589380. doi: 10.3389/fimmu.2020.589380 11. Liu X, Zhu A, He J, Chen Z, Liu L et al. Single-cell analysis reveals macrophage-driven T cell dysfunction in severe COVID-19 patients. Protein Cell 2020; 11: 680-687. doi: 10.1007/s13238-020- 00752-4 12. Henderson NC, Mackinnon AC, Farnworth SL, Kipari T, Haslett C et al. Galectin-3 expression and secretion links macrophages to the promotion of renal fibrosis. The American Journal of Pathology 2008; 172 (2): 2